Gepotidacin bulk supplier for pharma manufacturers

Gepotidacin 750mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 750mg

Reference Brands: Blujepa (USA)

Gepotidacin is a novel oral antibiotic belonging to the triazaacenaphthylene class. It works by inhibiting bacterial enzymes DNA gyrase and topoisomerase IV, which are essential for bacterial DNA replication, thereby preventing bacterial growth. Marketed under the brand name Blujepa in the USA, it is available as 750 mg tablets. It is primarily used to treat uncomplicated urinary tract infections (uUTIs) caused by susceptible bacteria in adults and adolescents.

Ask About Access

Quick Response Guaranteed | Verified Suppliers

Product Description:

Gepotidacin is a triazaacenaphthylene antibacterial — the first genuinely new class of oral antibiotic approved for uncomplicated urinary tract infection in nearly thirty years. It inhibits bacterial DNA replication by binding two type II topoisomerase enzymes at a site distinct from that used by fluoroquinolones. Because the binding site differs, existing fluoroquinolone resistance does not confer cross-resistance, which is the point of the molecule.

The US FDA approved it in March 2025 for uncomplicated UTI in female adults and adolescents from twelve years, against E. coli, Klebsiella pneumoniae, Citrobacter freundii, Staphylococcus saprophyticus and Enterococcus faecalis. It has since been approved for uncomplicated urogenital gonorrhoea, an indication of considerable public health importance given the narrowing treatment options in Neisseria gonorrhoeae. It is supplied as 750 mg tablets.

Sourcing notes. This is a newly approved, on-patent innovator product from a single manufacturer. No generic exists and none can lawfully exist for years; an offer of generic gepotidacin should be refused and investigated. Approvals outside the United States were still progressing through 2026, so availability is strictly market-dependent. Where a patient in an unapproved market requires it, named-patient import is the mechanism.

How Gepotidacin is actually supplied

Gepotidacin is a patented innovator medicine. There is no approved generic or biosimilar, which means it cannot be offered on a wholesale, bulk or third party manufacturing basis by us or by anyone else. Any party offering a generic version is offering something that does not lawfully exist, and that is worth treating as a warning rather than an opportunity.

Named-patient import Where a patient needs the product in a market where it is not registered, named-patient import is the lawful route. It requires the treating physician's documentation and authorisation from the destination regulator. We handle this pathway. Named-patient access

Authorised distribution For registered markets, supply runs through the manufacturer's authorised distribution channel. We can identify the authorised route for your market and tell you whether the product is registered there at all. Innovator sourcing

A genericised alternative Where the clinical requirement is the drug class rather than this specific molecule, there is often an off-patent alternative that is faster to register and materially cheaper. Tell us the indication and target market and we will say plainly whether one exists. Discuss alternatives

Ask about Gepotidacin supply →

Back to Listing

Frequently Asked Questions

Gepotidacin is listed as Tablets in 750mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Gepotidacin is referenced against Blujepa (USA). Reference brands are shown for identification only and remain the property of their respective trademark owners.